National Bank of Canada’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Buy |
903
+240
| +36% | +$78.3K | ﹤0.01% | 1241 |
|
|
2025
Q1 | $179K | Sell |
663
-5
| -0.7% | -$1.35K | ﹤0.01% | 1274 |
|
|
2024
Q4 | $157K | Buy |
668
+55
| +9% | +$13K | ﹤0.01% | 1330 |
|
|
2024
Q3 | $169K | Sell |
613
-13
| -2% | -$3.58K | ﹤0.01% | 1250 |
|
|
2024
Q2 | $152K | Sell |
626
-107,784
| -99% | -$26.2M | ﹤0.01% | 1254 |
|
|
2024
Q1 | $16.3M | Buy |
108,410
+107,897
| +21,033% | +$16.2M | 0.02% | 390 |
|
|
2023
Q4 | $100K | Buy |
513
+28
| +6% | +$5.46K | ﹤0.01% | 1413 |
|
|
2023
Q3 | $86.7K | Sell |
485
-2,781
| -85% | -$497K | ﹤0.01% | 1447 |
|
|
2023
Q2 | $620K | Buy |
3,266
+143
| +5% | +$27.1K | ﹤0.01% | 1123 |
|
|
2023
Q1 | $627K | Sell |
3,123
-1,109
| -26% | -$223K | ﹤0.01% | 1066 |
|
|
2022
Q4 | $1.01M | Sell |
4,232
-2,351
| -36% | -$559K | ﹤0.01% | 979 |
|
|
2022
Q3 | $1.3M | Sell |
6,583
-5,617
| -46% | -$1.11M | 0.01% | 784 |
|
|
2022
Q2 | $1.81M | Buy |
12,200
+11
| +0.1% | +$1.63K | 0.01% | 678 |
|
|
2022
Q1 | $2.05M | Buy |
12,189
+7,382
| +154% | +$1.24M | 0.01% | 714 |
|
|
2021
Q4 | $796K | Buy |
+4,807
| New | +$796K | ﹤0.01% | 972 |
|